Amount Raised
£6.5 Million
Round Type
Funding Round
Description
Manchester-based Biorelate has bagged £6.5m in Series A investment for its AI drug discovery platform for medical companies.
Quick answer
Biorelate raised £6.5 Million in a Funding Round round, dated November 29, 2022.
- How much did Biorelate raise?
- Biorelate raised £6.5 Million in a Funding Round round on November 29, 2022.
- What does Biorelate do?
- Biorelate helps scientists solving the most difficult biomedical challenges of today.
- Who are the decision-makers at Biorelate?
- Fundz holds 1 contact at Biorelate. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Artificial Intelligence around the same time
Companies in the same sectors as Biorelate that raised within 45 days of this round, from Fundz verified event records.
- Rocket One raised $10M on January 3, 2023.
- RegASK raised $10M (Series A) on December 15, 2022.
- In-Med Prognostics raised $2.1M (Seed) on December 12, 2022.
- Sonde Health raised $19M (Series B) on December 8, 2022.
- Vevo Therapeutics raised $12M (Seed) on December 8, 2022.
- Turbine raised $20M (Series A) on November 22, 2022.
Who to call at Biorelate, and when
A new round usually means Biorelate is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biorelate raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biorelate, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biorelate. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biorelate raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Biorelate raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.